Physician profile
Mark Khil
NPI 1851398598
$616.52
in general payments reported to CMS, 2019-2025
10 companies · $17.38 in 2025
The $17.38 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.71 · 2020: $18.96 · 2021: $62.84 · 2022: $44.26 · 2023: $18.96 · 2024: $381 · 2025: $17.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348 · Travel and Lodging: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.75 |
| Travel and Lodging | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $189.50 | 2024 | |
| Progenics Pharmaceuticals, INC. | $104.06 | 2024 | |
| Varian Medical Systems, INC. | $79.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $75.78 | 2021-2024 | |
| Siemens Medical Solutions USA, INC. | $59.83 | 2022-2024 | Somatom Go.Top, Truebeam, Varian Ethos Treatment Planning |
| Novartis Pharmaceuticals Corporation | $34.29 | 2024-2025 | |
| Myovant Sciences Gmbh | $22.92 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.51 | 2021 | |
| Boston Scientific Corporation | $18.96 | 2023 | Spaceoar Vue System - 10ml |
| Tactile Systems Technology INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Khil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.